{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:46:58Z","timestamp":1791269218269,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.transci.2015.05.016","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T06:48:56Z","timestamp":1434178136000},"page":"95-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing"],"prefix":"10.1016","volume":"53","author":[{"given":"Ching-Li","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerard","family":"Seghatchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2015.05.016_bib0010","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/trf.12068","article-title":"Virally inactivated human platelet concentrate lysate induces regulatory T cells and immunosuppressive effect in a murine asthma model","volume":"53","author":"Lee","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.05.016_bib0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00167-011-1570-5","article-title":"Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study","volume":"20","author":"Cervellin","year":"2012","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.transci.2015.05.016_bib0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","article-title":"Platelet-rich plasma for managing pain and inflammation in osteoarthritis","volume":"9","author":"Andia","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.transci.2015.05.016_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.blre.2013.02.001","article-title":"Blood-derived biomaterials and platelet growth factors in regenerative medicine","volume":"27","author":"Burnouf","year":"2013","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2015.05.016_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbt.2014.06.001","article-title":"Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion","volume":"32","author":"Shih","year":"2015","journal-title":"N Biotechnol"},{"key":"10.1016\/j.transci.2015.05.016_bib0035","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1634\/stemcells.2006-0627","article-title":"Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue","volume":"25","author":"Kocaoemer","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.transci.2015.05.016_bib0040","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1537-2995.2007.01220.x","article-title":"Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells","volume":"47","author":"Schallmoser","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.05.016_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099145","article-title":"Ex vivo expansion of bovine corneal endothelial cells in xeno-free medium supplemented with platelet releasate","volume":"9","author":"Chou","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.transci.2015.05.016_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2011.09.017","article-title":"Human blood-derived fibrin releasates: composition and use for the culture of cell lines and human primary cells","volume":"40","author":"Burnouf","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.transci.2015.05.016_bib0055","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1046\/j.1537-2995.2001.41101186.x","article-title":"Topical platelet growth factor therapy: of lotions and potions","volume":"41","author":"Snyder","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.05.016_bib0060","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2174\/138920112800624454","article-title":"Platelet concentrates for topical use: bedside device and blood transfusion technology. Quality and versatility","volume":"13","author":"Borzini","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.transci.2015.05.016_bib0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.transci.2014.08.006","article-title":"Multifaceted regenerative lives of expired platelets in the second decade of the 21st century","volume":"51","author":"Burnouf","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2015.05.016_bib0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly","volume":"124","author":"Schein","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.transci.2015.05.016_bib0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2015.05.016_bib0080","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1537-2995.2008.01665.x","article-title":"Autologous serum eyedrops: literature review and implications for transfusion medicine specialists","volume":"48","author":"Yamada","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.05.016_bib0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1755-3768.1992.tb02169.x","article-title":"Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations","author":"van Setten","year":"1992","journal-title":"Acta Ophthalmol Suppl (Oxf)"},{"key":"10.1016\/j.transci.2015.05.016_bib0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/bjo.87.10.1279","article-title":"Albumin as a tear supplement in the treatment of severe dry eye","volume":"87","author":"Shimmura","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2015.05.016_bib0095","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1167\/iovs.04-1326","article-title":"The controlled environment chamber: a new mouse model of dry eye","volume":"46","author":"Barabino","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2015.05.016_bib0100","author":"Fawcett"},{"key":"10.1016\/j.transci.2015.05.016_bib0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2415-13-50","article-title":"Establishment of the mild, moderate and severe dry eye models using three methods in rabbits","volume":"13","author":"Li","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.transci.2015.05.016_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2015.05.016_bib0115","first-page":"308","article-title":"Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas","volume":"19","author":"Burstein","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2015.05.016_bib0120","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","article-title":"A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride","volume":"49","author":"Xiong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2015.05.016_bib0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000109986","article-title":"Acute corneal epithelial change after instillation of BAC evaluated using a newly developed in vivo cornea","volume":"39","author":"Uematsu","year":"2007","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.transci.2015.05.016_bib0130","first-page":"257","article-title":"A mouse dry eye model induced by topical administration of benzalkonium chloride","volume":"17","author":"Lin","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.transci.2015.05.016_bib0135","article-title":"Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.transci.2015.05.016_bib0140","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1167\/iovs.13-13577","article-title":"Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model","volume":"13","author":"Zhang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2015.05.016_bib0145","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1167\/iovs.03-1055","article-title":"Animal models of dry eye: a critical assessment of opportunities and limitations","volume":"45","author":"Barabino","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2015.05.016_bib0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1537-2995.2004.00382.x","article-title":"Platelet-derived growth factor-AB and transforming growth factor-beta 1 in platelet gels activated by single-donor human thrombin","volume":"44","author":"Su","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.05.016_bib0155","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1537-2995.2011.03494.x","article-title":"Human platelet concentrates: a source of solvent\/detergent-treated highly enriched brain-derived neurotrophic factor","volume":"52","author":"Burnouf","year":"2012","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050215001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050215001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:18:35Z","timestamp":1748449115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050215001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1473050215001093"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2015.05.016","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2015.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}